Abstract
(117 words) Acute and recurrent pericarditis, isolated pericardial effusion, and constrictive pericarditis represent the main pericardial syndromes and therapy of these conditions should be targeted as much as possible at the specific aetiology, but unfortunately many cases still remain idiopathic with current diagnostic methods and should be empirically treated according to best available evidence. Unfortunately, treatment is often empirical since there are few clinical trials available. Nevertheless as for hypertension, even if we do not know the precise cause of the syndrome in all cases, we may provide excellent management for most cases. The aim of the present paper is to review current medical therapy for the main pericardial syndromes.
Keywords: Pericarditis, pericardial effusion, cardiac tamponade, constrictive pericarditis, therapy.
Current Pharmaceutical Design
Title:Pharmacological Therapy of Pericardial Diseases
Volume: 21 Issue: 4
Author(s): Massimo Imazio and Yehuda Adler
Affiliation:
Keywords: Pericarditis, pericardial effusion, cardiac tamponade, constrictive pericarditis, therapy.
Abstract: (117 words) Acute and recurrent pericarditis, isolated pericardial effusion, and constrictive pericarditis represent the main pericardial syndromes and therapy of these conditions should be targeted as much as possible at the specific aetiology, but unfortunately many cases still remain idiopathic with current diagnostic methods and should be empirically treated according to best available evidence. Unfortunately, treatment is often empirical since there are few clinical trials available. Nevertheless as for hypertension, even if we do not know the precise cause of the syndrome in all cases, we may provide excellent management for most cases. The aim of the present paper is to review current medical therapy for the main pericardial syndromes.
Export Options
About this article
Cite this article as:
Imazio Massimo and Adler Yehuda, Pharmacological Therapy of Pericardial Diseases, Current Pharmaceutical Design 2015; 21 (4) . https://dx.doi.org/10.2174/138161282104141204144622
DOI https://dx.doi.org/10.2174/138161282104141204144622 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recurrent Episodes of Pericardial Effusion as Isolated Manifestation of Tuberculosis: Case Report
Current Medical Imaging The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice
Current Respiratory Medicine Reviews Safety and Efficacy of Bridging with Low Molecular Weight Heparins: A Systematic Review and Partial Meta-Analysis
Current Pharmaceutical Design COMPLICATIONS OF RECANALIZATION OF CHRONIC TOTAL OCCLUSION
Current Cardiology Reviews Deep Neck Infections: Decisional Algorithm for Patients with Multiple Spaces Involvement
Reviews on Recent Clinical Trials Indications of Anti-Inflammatory Drugs in Cardiac Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews Microvascular Obstruction After Primary Percutaneous Coronary Intervention: Pathogenesis, Diagnosis and Prognostic Significance
Current Vascular Pharmacology Ovarian Cancer - Angiogenesis and Targeted Therapy
Current Angiogenesis (Discontinued) Cardiac Involvement in ANCA (+) and ANCA (-) Churg-Strauss Syndrome Evaluated by Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Mesothelioma - Epidemiology and Management
Current Respiratory Medicine Reviews Clozapine Safety, 40 Years Later
Current Drug Safety Pulmonary Valve Endocarditis: A Case Report
Infectious Disorders - Drug Targets Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets Malignant Pleural Mesothelioma in 2011. Is there a Gold Standard Therapy?
Current Respiratory Medicine Reviews Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
Current Drug Targets Adrenomedullin-RAMP2 System in Cardiovascular Development and Homeostasis
Current Hypertension Reviews Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies
Current Drug Targets Diagnosis of Systemic Lupus Erythematosus in an Unusual Presentation: What a Primary Care Physician Should Know
Current Rheumatology Reviews Coronary Intravascular Ultrasound (IVUS): Contemporary Applications and Bases for the Future
Recent Patents on Medical Imaging